XENPOZYME

This brand name is authorized in Austria, France, Croatia, Israel, Italy, Japan, Lithuania, Romania

Active ingredients

The drug XENPOZYME contains one active pharmaceutical ingredient (API):

1 Olipudase alfa UNII 6D5766Q4OP - OLIPUDASE ALFA

Olipudase alfa is a recombinant human acid sphingomyelinase that reduces sphingomyelin (SM) accumulation in organs of patients with Acid Sphingomyelinase Deficiency (ASMD). Read about Olipudase alfa

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XENPOZYME Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AB	Enzymes	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products
Discover more medicines within A16AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63908675
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9277
Country: IT	Agenzia del Farmaco	Identifier(s): 050121019, 050121021, 050121033, 050121045, 050121058, 050121060, 050121072
Country: JP	医薬品医療機器総合機構	Identifier(s): 3959426D1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095026, 1095027, 1095028, 1095029
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68945001, W68945002